TL;DR: Alixia is a Y Combinator Winter 2022 startup Targeting the Tumor Ecosystem to address cancer drug resistance., currently active with a team of 2.
Targeting the Tumor Ecosystem to address cancer drug resistance.
Last verified:
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.
Built by LemStudio
Yes. Alixia was funded by Y Combinator in the Winter 2022 batch. Targeting the Tumor Ecosystem to address cancer drug resistance.
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.
Alixia was part of Y Combinator's Winter 2022 batch.
Alixia has a team of 2 people according to Y Combinator's directory.
Alixia is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…